Related Experiment Video
Updated: Jul 10, 2026

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
Published on: May 2, 2013
Improved renal allograft survival with vitamin D receptor polymorphism
P J Lavin1, M E Laing, P O'Kelly
1Department of Nephrology, Beaumont Hospital, Dublin 9, Ireland. plavin@chg.duhs.duke.edu
Background:
Polymorphisms in genes, coding for proteins involved in immune response, or the pathogenesis of atherosclerosis may influence immunological and non-immunological mechanisms that lead to allograft loss. Vitamin D receptor (VDR) agonists reduce allograft rejection in animal models, and there are a number of functional polymorphisms in VDR.
Methods:
In all, 379 renal transplant recipients were genotyped for VDR (FokI & ApaI) polymorphisms, and the association of each genotype with renal allograft survival and acute rejection was determined.
Results:
There was significantly improved allograft survival for patients who were homozygous or heterozygous for the VDR FokI T allele (Hazard Ratio [HR] = 0.488, p < 0.001).
Conclusion:
The association of VDR FokI T allele with improved renal allograft survival is a unique observation. The finding is in keeping with data showing the prevention of chronic allograft rejection with the use of Vitamin D receptor agonists.
Insights
The Vitamin D Receptor (VDR) FokI T allele is linked to better kidney transplant survival. This genetic finding supports using VDR agonists to prevent transplant rejection.
Area of Science:
- Transplantation immunology
- Genetics
- Renal medicine
Background:
- Allograft loss can result from immune and non-immune factors influencing atherosclerosis and immune response.
- Vitamin D receptor (VDR) agonists have shown promise in reducing allograft rejection in animal studies.
- Functional polymorphisms within the VDR gene present potential targets for investigation.
Purpose of the Study:
- To investigate the association between VDR gene polymorphisms (FokI and ApaI) and renal allograft survival.
- To determine the impact of these genotypes on acute rejection rates in kidney transplant recipients.
Main Methods:
- Genotyping of 379 renal transplant recipients for VDR FokI and ApaI polymorphisms.
- Statistical analysis to correlate genotypes with allograft survival and acute rejection events.
Main Results:
- A significant improvement in renal allograft survival was observed in patients with the VDR FokI T allele (homozygous or heterozygous).
- The Hazard Ratio for allograft loss was significantly reduced (HR = 0.488, p < 0.001) for carriers of the VDR FokI T allele.
Conclusions:
- The VDR FokI T allele is uniquely associated with enhanced renal allograft survival.
- This genetic association aligns with evidence suggesting VDR agonists can prevent chronic allograft rejection.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure